idarubicin has been researched along with Adenocarcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldayel, AS; Konoplev, S; Medeiros, LJ; Rich, A; Sun, J; Yin, CC | 1 |
| Iland, HJ; Mohamed, M; Sharma, S; Supple, SG | 1 |
| Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M | 1 |
| Dandekar, P; Jain, R; Koch, M; Lehr, CM; Loretz, B; Melero, A; Stauner, T; Wenz, G | 1 |
| Cho, JH; Hur, M; Kim, WS; Ko, YS; Lee, MH; Moon, HW; Yun, YM | 1 |
| Alberto, P; Cavalli, F; Joss, RA; Obrecht, JP; Siegenthaler, P; VanHelvoirt, A | 1 |
| Cheng, E; Einzig, A; Kelsen, D; Magill, G; Raymond, V; Sordillo, P | 1 |
| Baccarani, M; Cerno, M; Damiani, D; Melli, C; Michelutti, A; Michieli, M | 1 |
| Berti, E; Berti, T; Carrara, M; D'Ancona, S; Ragazzi, E | 1 |
| Gupta, S; Hirsch, G; MacCormick, R; Rotstein, L; Shannon, P | 1 |
| Abad-Esteve, A; Diaz-Rubio, E; Gonzalez-Larriba, JL; Jimeno, JM; Rosell, R; Villar, A | 1 |
| Daghestani, AN; Dougherty, JB; Hakes, TB; Raymond, V; Weiselberg, L | 1 |
2 review(s) available for idarubicin and Adenocarcinoma
| Article | Year |
|---|---|
Myelomastocytic leukemia with aberrant CD25 expression: case report and review of the literature.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Brain; Cerebral Hemorrhage; Cytarabine; Fatal Outcome; Humans; Hydroxamic Acids; Idarubicin; Interleukin-2 Receptor alpha Subunit; Leukemia, Myeloid, Acute; Leukemic Infiltration; Male; Mast Cells; Middle Aged; Neoplasms, Second Primary; Neoplastic Stem Cells; Opportunistic Infections; Prostatectomy; Prostatic Neoplasms; Vorinostat | 2014 |
Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Back; Benzamides; Bone Marrow; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Endometrial Neoplasms; Female; Gene Rearrangement; Genes, abl; Humans; Idarubicin; Imatinib Mesylate; Immunophenotyping; Induction Chemotherapy; Karyotyping; Leukemia, Myeloid, Acute; Leukemic Infiltration; Middle Aged; Neoplasms, Second Primary; Piperazines; Pyrimidines; Remission Induction; Soft Tissue Neoplasms; Submandibular Gland Neoplasms; Translocation, Genetic | 2012 |
1 trial(s) available for idarubicin and Adenocarcinoma
| Article | Year |
|---|---|
A phase II study of idarubicin in the treatment of measurable gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Canada; Drug Evaluation; Female; Humans; Idarubicin; Male; Middle Aged; Remission Induction; Stomach Neoplasms | 1991 |
9 other study(ies) available for idarubicin and Adenocarcinoma
| Article | Year |
|---|---|
Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
Topics: Acute Disease; Adenocarcinoma; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Colorectal Neoplasms; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Second Primary; Organoplatinum Compounds; Oxaliplatin; Pancytopenia; Primary Myelofibrosis; Remission Induction; Tretinoin | 2016 |
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin | 2010 |
Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adsorption; Antibiotics, Antineoplastic; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; HT29 Cells; Humans; Idarubicin; Kinetics; Lung Neoplasms; Microscopy, Confocal; Nanoparticles; Nanotechnology; Particle Size; Polyvinyl Alcohol; Protein Binding; Pterins; Solubility; Starch; Surface-Active Agents; Technology, Pharmaceutical | 2011 |
Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Daunorubicin; Digestive System; Drug Evaluation; Heart; Humans; Idarubicin; Leukopenia; Lung Neoplasms; Middle Aged | 1984 |
Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Daunorubicin; Drug Evaluation; Esophageal Neoplasms; Humans; Idarubicin; Stomach Neoplasms | 1984 |
D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Survival; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured; Verapamil | 1993 |
A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Colonic Neoplasms; Cyclophosphamide; Dipyridamole; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Idarubicin; Mitoxantrone; Neoplasm Proteins; Teniposide; Tumor Cells, Cultured; Verapamil; Vinblastine | 1999 |
Oral idarubicin in measurable gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Male; Middle Aged; Stomach Neoplasms | 1989 |
Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Granulosa Cell Tumor; Humans; Idarubicin; Middle Aged; Ovarian Neoplasms | 1985 |